Study of Natalizumab in Relapsed/Refractory Multiple Myeloma
Clinical trial NCT00675428 · TERMINATED
Trial details
- NCT number
- NCT00675428
- Sponsor
- Biogen
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2009-12-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.